IDEAS home Printed from https://ideas.repec.org/a/eee/ecanpo/v89y2026icp421-441.html

Industry regulation and firm innovation: Evidence from national centralized drug procurement policy in China

Author

Listed:
  • Zhang, Siyu
  • Huang, Yuexin
  • Luo, Danglun

Abstract

Promoting innovation in pharmaceutical manufacturing is crucial for national health. This study investigates the impact of industry regulations on firm innovation by analyzing China's national centralized drug procurement (NCDP) policy. The findings indicate that the regulatory reform has effectively stimulated innovation among pharmaceutical enterprises, particularly non-state-owned ones, which lack political connections, are relatively small in scale, and operate in challenging market environments. The reform exerts its influence by changing product market competition patterns, including altering competition strategies, and intensifying competitive pressures. This study provides empirical evidence supporting the efficacy of industry regulations and offers insights for fostering innovation and development in pharmaceutical enterprises through the lens of market competition.

Suggested Citation

  • Zhang, Siyu & Huang, Yuexin & Luo, Danglun, 2026. "Industry regulation and firm innovation: Evidence from national centralized drug procurement policy in China," Economic Analysis and Policy, Elsevier, vol. 89(C), pages 421-441.
    • Handle: RePEc:eee:ecanpo:v:89:y:2026:i:c:p:421-441
    DOI: 10.1016/j.eap.2025.12.013
    as

    Download full text from publisher

    File URL: http://www.sciencedirect.com/science/article/pii/S0313592625004965
    Download Restriction: Full text for ScienceDirect subscribers only
    File URL: https://libkey.io/10.1016/j.eap.2025.12.013?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    As the access to this document is restricted, you may want to

    for a different version of it.

    More about this item

    Keywords

    ;
    ;
    ;
    ;

    JEL classification:

    • G38 - Financial Economics - - Corporate Finance and Governance - - - Government Policy and Regulation
    • G31 - Financial Economics - - Corporate Finance and Governance - - - Capital Budgeting; Fixed Investment and Inventory Studies
    • L51 - Industrial Organization - - Regulation and Industrial Policy - - - Economics of Regulation

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:eee:ecanpo:v:89:y:2026:i:c:p:421-441. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    We have no bibliographic references for this item. You can help adding them by using this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Catherine Liu (email available below). General contact details of provider: http://www.journals.elsevier.com/economic-analysis-and-policy .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.